Murakami, S., Shibaki, R., Matsumoto, Y., Yoshida, T., Goto, Y., Kanda, S., . . . Ohe, Y. (2020). Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with anti‐PD‐1 antibody. Thorac Cancer.
Citação norma ChicagoMurakami, Shuji, et al. "Association between Serum Level Soluble Programmed Cell Death Ligand 1 and Prognosis in Patients With Non‐small Cell Lung Cancer Treated With Anti‐PD‐1 Antibody." Thorac Cancer 2020.
Citação norma MLAMurakami, Shuji, et al. "Association between Serum Level Soluble Programmed Cell Death Ligand 1 and Prognosis in Patients With Non‐small Cell Lung Cancer Treated With Anti‐PD‐1 Antibody." Thorac Cancer 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.